|
297 Further tensions
emerge over royal college model Further
differences emerged last week over how membership of a royal-college-type
body for the profession would be conferred or obtained. A range of opinions
over how membership should be determined were first mooted shortly after
publication of the White Paper
PJ 2007;278:297
Full Text
297 Irish republic leads in regulation
shake-up A radical shake-up of the pharmacy
sector in the Irish Republic is proposed in a new bill that is expected
to become law by Easter
PJ 2007;278:297
Full Text
297 NHS staff in Scotland will avoid staged
increase in pay NHS staff in Scotland are to be
given the full 2.5 per cent pay increase on 1 April, rather than the staged increase
announced in England
PJ 2007;278:297
Full Text
298 Diabetes progress report
ignores pharmacy's role Improvements in services
for people with diabetes continue to be seen across the NHS but there are still
gaps that need to be filled, a report published by the Department of Health last
week reveals
PJ 2007;278:298
Full Text
298 First in a new class of medicines to treat
type 2 diabetes launched Exenatide (Byetta), the
first in a new class of medicines to treat type 2 diabetes, was launched at the
Diabetes UK annual conference in Glasgow this week
PJ 2007;278:298
Full Text
298 Pioglitazone as well as rosiglitazone increases
fractures in women Pioglitazone (Actos; Takeda)
increases fracture risks in women with diabetes, a new analysis of clinical trial
data reported by the US Food and Drug Administration indicates
PJ 2007;278:298
Full Text
299 Bigger role for pharmacists
in seasonal flu vaccination scheme? Community pharmacists
in England could be set to play a bigger role in delivering the seasonal influenza
programme following an independent review of the programme commissioned by the
Department of Health
PJ 2007;278:299
Full Text
299Alliance Boots rejects initial £9.7bn takeover approach Alliance Boots has rejected a £9.7bn takeover approach from US-based KKR private equity group
PJ 2007;278:299
Full Text
299 New NPA health campaign targets students New routes are being used by the National Pharmacy Association to promote its “Ask your pharmacist” campaign
PJ 2007;278:299
Full Text
299 Flu vaccine update Community
pharmacists in Scotland can order influenza vaccines from the same supplier and
still receive the risk minimisation payment, provided the vaccines are separate
brands made at different sites, says an NHS circular published this week
PJ 2007;278:299
Full Text
299 Paediatric trials SIG A
special interest group focusing on clinical trials in children has been established
by the Institute of Clinical Research
PJ 2007;278:299
Full Text
300 CD handling to be in annual
Healthcare Commission check How well NHS trusts manage Controlled Drugs is to be assessed as part of the Healthcare Commission's annual health check for 2007–08
PJ 2007;278:300
Full Text
300 Latest figures show level of health care-associated
infections in acute hospitals Health care-associated infections are experienced by 8.2 per cent of patients in acute hospitals in England, new figures show
PJ 2007;278:300
Full Text
300 Alliance launched in Scotland to improve
patient safety in hospitals A new patient safety
programme called the Scottish Patient Safety Alliance was launched this week
PJ 2007;278:300
Full Text
300 SMC accepts five medicines, rejects four,
in latest advice Pioglitazone (Actos) has been accepted for use within NHS Scotland to treat type 2 diabetes as part of a triple therapy regimen with metformin and a sulphonylurea
PJ 2007;278:300
Full Text
301 Call for shift in pharmacists'
core ethical values Pharmacists should reorient
their values to shift the emphasis from concern with a patient's best interests
towards respect for people, according to a report published by the Pharmacy Practice
Research Trust
PJ 2007;278:301
Full Text
301 Society gives evidence to Galbraith review Evidence
on the community pharmacy contract in England was presented by the Royal Pharmaceutical
Society to Anne Galbraith's contract review last week
PJ 2007;278:301
Full Text
301 Scottish strategy tackles health of ageing
population Improving health is identified as a
key objective in a strategy for older people, published this week by the Scottish
Executive
PJ 2007;278:301
Full Text
301 Clare Mackie made pro vice-chancellor Clare
Mackie, head of Medway School of Pharmacy, has been appointed pro vice-chancellor
of the University of Kent at Medway. Professor Mackie will be the university's
first pro vice-chancellor and will take up the post on 1 September 2007
PJ 2007;278:301
Full Text
301 Full accreditation for UEA The
MPharm degree at the University of East Anglia has been given full accreditation
for a period of five years
PJ 2007;278:301
Full Text
301 Co-op is biggest in Wales Co-operative
Group Pharmacy has acquired 12 Matthew Price pharmacies
PJ 2007;278:301
Full Text
301 Bowel cancer screening Bowel
cancer screening is to be rolled out in Scotland, with home tests being sent
to people aged between 50 and 74 years
PJ 2007;278:301
Full Text
302 Additives in child medicines
opposed by food group Medicines manufacturers have
been criticised by food campaigners for including additives in medicines for
young children that are banned from foods aimed at the same age group
PJ 2007;278:302
Full Text
302 Lloydspharmacy escapes paying damages Lloydspharmacy
could escape having to pay damages to US lawyer Cathy Horton, who sued the company
after suffering ill-health caused by an excessive dose of steroids
PJ 2007;278:302
Full Text
302 Pfizer warned over misleading advertisements
for Zyvox Pfizer has been told by the Medicines
and Healthcare products Regulatory Agency to stop all advertising for Zyvox (linezolid)
that contains misleading information about the antibiotic
PJ 2007;278:302
Full Text
302 Clubs given gas warning Nightclubs
and festival organisers have been warned that they face prosecution if they sell
nitrous oxide (laughing gas) for recreational inhalation because it is a pharmacy
medicine
PJ 2007;278:302
Full Text
302 Stroke patients with impairment of executive
functioning could benefit from antidepressants Antidepressants can improve long-term so-called “executive” functioning in stroke patients, a new study indicates
PJ 2007;278:302
Full Text
R&D news
303 Initial data on CCR5 inhibitor for HIV look
promising A new class of anti-HIV drug, the orally
available CCR5 entry inhibitor maraviroc, looks promising in initial 24-week
data first presented at the 14th Conference on Retroviruses and Opportunistic
Infections in Los Angeles last month
PJ 2007;278:303
Full Text
303 Oral integrase inhibitor active at 16 weeks Early data from phase III studies of Merck Sharp & Dohme's raltegravir (formerly known as MK-0518) indicate that the oral integrase inhibitor has greater antiretroviral activity than placebo in treatment-resistant patients infected with HIV
PJ 2007;278:303
Full Text
303 Potential new target for Alzheimer's disease
identified Researchers have identified a new therapeutic target — casein kinase 1 — that they say could lead to drugs that treat Alzheimer's disease without causing side effects
PJ 2007;278:303
Full Text
303 Hepatitis E vaccine effective A
recombinant hepatitis E vaccine has been shown to be effective in a high-risk
population
PJ 2007;278:303
Full Text
303 Certolizumab promising for RA Certolizumab — the first pegylated, Fc-free anti-tumour necrosis factor antibody — has shown promising results for rheumatoid arthritis in phase III trials
PJ 2007;278:303
Full Text
|
The
Pharmaceutical Journal